Abstract

Introduction/BackgroundPresence of residual disease (RD) after interval debulking surgery (IDB) is an important negative prognostic factor for patients with advanced stage epithelial ovarian cancer (EOC). Surgery is of limited benefit...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4
Pien Lof ... Christianne A R Lok
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. 67
Pien Lof, et. al.Pien Lof ... Christianne A R Lok
11 Sep 2019
State of the art of surgery in advanced epithelial ovarian cancer
N.F Hacker
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 24
N.F HackerN.F Hacker
01 Dec 2013
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Shaun Hiu ... Dawn Craig
The Cochrane database of systematic reviews | VOL. 9
Shaun Hiu, et. al.Shaun Hiu ... Dawn Craig
26 Sep 2022
Interval debulking surgery for advanced epithelial ovarian cancer.
Siriwan Tangjitgamol ... Pisake Lumbiganon
The Cochrane database of systematic reviews | VOL. -
Siriwan Tangjitgamol, et. al.Siriwan Tangjitgamol ... Pisake Lumbiganon
30 Apr 2013
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Predictive factors for adnexal involvement in endometrial cancer FIGO stage IIIA
Giorgia Dinoi ... Francesco Fanfani
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Giorgia Dinoi, et. al.Giorgia Dinoi ... Francesco Fanfani
13 Jul 2024
Role of V-Y flap reconstruction in vulvar cancer patients: multicenter retrospective study
Violante Di Donato ... Giorgio Bogani
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Violante Di Donato, et. al.Violante Di Donato ... Giorgio Bogani
13 Jul 2024
Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients
Erika J Lampert ... Mariam M Alhilli
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Erika J Lampert, et. al.Erika J Lampert ... Mariam M Alhilli
13 Jul 2024
Antibody–drug conjugate targeting folate receptor α: a new milestone in personalized medicine for high-grade serous ovarian cancer
Antonio Gonzalez-Martin
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Antonio Gonzalez-MartinAntonio Gonzalez-Martin
10 Jul 2024
View more papers